<!DOCTYPE html>
<html lang="en">
    <head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1">
        <title>38</title>

        <link href="bootstrap.min.css" rel="stylesheet">
        <link href="custom_arrow.css" rel="stylesheet" type="text/css"/>
        <link href="treatments.css" rel="stylesheet" type="text/css"/>
        <link href="recreated_tables.css" rel="stylesheet" type="text/css"/>
           <style>
        .sep {
            border-bottom:1px solid lightgray;
        }
        .sep td {
            padding-bottom:5px;
            padding-top:5px;
        }
        br {
            display: block;
            margin-top: 5px 0;
        }
    </style>
    </head>
    <body>
            <br />
            <div class="container">
                <ol class="breadcrumb small">
                
                        <li class="active">Pediculosis Pubis</li>
                </ol>
              </div><!-- end of breadcrumbs -->
            
        <div class="container"><p>Persons who have pediculosis pubis (i.e., pubic lice) usually seek medical attention because of pruritus or because they notice lice or nits on their pubic hair. Pediculosis pubis is usually transmitted by sexual contact <sup id="fnref:849"><a class="footnote-ref" href="#fn:849" rel="footnote">1</a></sup>.</p>
<h3>Treatment</h3>
<p>Reported resistance to pediculcides (permethrin and pyrethrins) has been increasing and is widespread <sup id="fnref:850"><a class="footnote-ref" href="#fn:850" rel="footnote">2</a></sup>  <sup id="fnref:851"><a class="footnote-ref" href="#fn:851" rel="footnote">3</a></sup>. Malathion can be used when treatment failure is believed to have occurred as a result of resistance. The odor and long duration of application associated with malathion therapy make it a less attractive alternative compared with the recommended pediculcides. Ivermectin has limited ovicidal activity <sup id="fnref:852"><a class="footnote-ref" href="#fn:852" rel="footnote">4</a></sup>. Ivermectin might not prevent recurrences from eggs at the time of treatment, and therefore treatment should be repeated in 14 days <sup id="fnref:853"><a class="footnote-ref" href="#fn:853" rel="footnote">5</a></sup>  <sup id="fnref:854"><a class="footnote-ref" href="#fn:854" rel="footnote">6</a></sup>. Ivermectin should be taken with food because bioavailability is increased, in turn increasing penetration of the drug into the epidermis. Adjustment of ivermectin dosage is not required for persons with renal impairment, but the safety of multiple doses in persons with severe liver disease is not known.</p>
<p>Lindane is recommended as an alternative therapy because it can cause toxicity, as indicated by seizure and aplastic anemia <sup id="fnref:855"><a class="footnote-ref" href="#fn:855" rel="footnote">7</a></sup>; it should only be used when other therapies cannot be tolerated or have failed. Lindane toxicity has not been reported when treatment was limited to the recommended 4-minute period. Lindane should not be used immediately after a bath or shower, and it should not be used by persons who have extensive dermatitis, women who are breastfeeding, or children aged &lt;10 years <sup id="fnref:855"><a class="footnote-ref" href="#fn:855" rel="footnote">7</a></sup>.</p>
<div class="footnote">
<hr />
<ol>
<li id="fn:849">
<p>Galiczynski EM, Jr., Elston DM. What's eating you? Pubic lice (Pthirus pubis). Cutis 2008;81:109–14.&#160;<a class="footnote-backref" href="#fnref:849" rev="footnote" title="Jump back to footnote 1 in the text">&#8617;</a></p>
</li>
<li id="fn:850">
<p>Meinking TL, Serrano L, Hard B, et al. Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. Arch Dermatol 2002;138:220–4.&#160;<a class="footnote-backref" href="#fnref:850" rev="footnote" title="Jump back to footnote 2 in the text">&#8617;</a></p>
</li>
<li id="fn:851">
<p>Yoon KS, Gao JR, Lee SH, et al. Permethrin-resistant human head lice, Pediculus capitis, and their treatment. Arch Dermatol 2003;139:994–1000.&#160;<a class="footnote-backref" href="#fnref:851" rev="footnote" title="Jump back to footnote 3 in the text">&#8617;</a></p>
</li>
<li id="fn:852">
<p>Burkhart CG, Burkhart CN. Oral ivermectin for Phthirus pubis. J Am Acad Dermatol 2004;51:1037–8.&#160;<a class="footnote-backref" href="#fnref:852" rev="footnote" title="Jump back to footnote 4 in the text">&#8617;</a></p>
</li>
<li id="fn:853">
<p>Scott GR, Chosidow O. European guideline for the management of pediculosis pubis, 2010. International journal of STD and AIDS 2011;22:304–5.&#160;<a class="footnote-backref" href="#fnref:853" rev="footnote" title="Jump back to footnote 5 in the text">&#8617;</a></p>
</li>
<li id="fn:854">
<p>Goldust M, Rezaee E, Raghifar R, et al. Comparing the efficacy of oral ivermectin vs malathion 0.5% lotion for the treatment of scabies. SkinMed 2014;12:284–7.&#160;<a class="footnote-backref" href="#fnref:854" rev="footnote" title="Jump back to footnote 6 in the text">&#8617;</a></p>
</li>
<li id="fn:855">
<p>Nolan K, Kamrath J, Levitt J. Lindane toxicity: a comprehensive review of the medical literature. Pediatr Dermatol 2012;29:141–6.&#160;<a class="footnote-backref" href="#fnref:855" rev="footnote" title="Jump back to footnote 7 in the text">&#8617;</a></p>
</li>
</ol>
</div>
        </div>
            </div>
        </div>
    </body>
</html>
        